This content from the 2020 ASCRS Virtual Annual Meeting is only available to ASCRS members. To log in, click the teal "Login" button in the upper right-hand corner of this page.
To describe a new technique for Descemet membrane endothelial keratoplasty (DMEK) in aphakic and vitrectomized eyes.
This is a retrospective case series performed in a tertiary cornea practice. The study included five eyes which underwent DMEK surgery for corneal endothelial insufficiency for aphakic bullous keratopathy utilizing a new “Parachute” technique. Cases were reviewed for intra- and postoperative complications, postoperative clearing of the cornea, best corrected visual acuity, and endothelial cell loss.
The mean BCVA improved from 1.56±0.68 LogMAR to 1.32±0.74 LogMAR at post-operative month 1 and to 1.10±0.81 at post-operative month 3. The mean endothelial cell density decreased from 2181±697 cells/mm2 pre-optatively to 2018±760 cells/mm2 3 months after surgery. No complications were recorded.
A new technique of DMEK is a safe and effective method to manage bullous keratopathy in aphakic and vitrectomized eyes.
This presentation is from the session "SPS-101 Corneal Procedures & Diagnostics: EK, PK, CXL, Other" from the 2020 ASCRS Virtual Annual Meeting held on May 16-17, 2020.